• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期的住院预测因素:一项多中心回顾性分析的事后研究

Hospitalization Predictors in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Post Hoc Study of a Multicentric Retrospective Analysis.

作者信息

Salai Grgur, Tokić Vukan-Ćusa Tatjana, Vergles Mirna, Škrinjarić Cincar Sanda, Ostojić Jelena, Škoro Matea, Vrbica Žarko, Lozo Vukovac Emilija, Tudorić Neven, Vukić Dugac Andrea

机构信息

Department of Pulmonology, Dubrava University Hospital, 10000 Zagreb, Croatia.

Faculty of Medicine, University of Osijek, 31000 Osijek, Croatia.

出版信息

J Clin Med. 2025 Apr 21;14(8):2855. doi: 10.3390/jcm14082855.

DOI:10.3390/jcm14082855
PMID:40283683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12028299/
Abstract

: Hospitalizations for acute exacerbations in patients with chronic obstructive pulmonary disease (AECOPD) are connected with considerable mortality and morbidity and have a great impact on healthcare costs. We aimed to identify potentially important characteristics that distinguish patients with AECOPD that required hospitalization between those that did not. : We performed a post hoc study of a previously conducted observational study assessing the discharge records of AECOPD patients who were either hospitalized or discharged directly from the emergency department (ED). : A total of N = 593 AECOPD patients (37.4% female) were included: N = 225 (37.9%) were hospitalized, while 368 (62.1%) were discharged from the ED. Patients had a mean age of 71 (±9.14) years. Further, 64.7% had arterial hypertension, and 60.4% of hospitalized and 42.1% of discharged patients had cardiovascular disease (excluding hypertension) ( < 0.001). In addition, 24% of hospitalized patients suffered from diabetes mellitus (vs. 16.8% of those discharged, = 0.042). Patients that were discharged had a higher median eosinophil count than hospitalized patients ( < 0.001). Among the 368 patients discharged from the ED, 23.6% visited the ED due to AECOPD, and 50.6% were hospitalized in the subsequent three months. Patients that had at least one AECOPD in the subsequent three months had significantly lower initial eosinophil counts than those that did not ( = 0.015). : Hospitalized AECOPD patients had a higher prevalence of pre-existing cardiovascular disease, diabetes mellitus and lower blood eosinophil counts. Patients that had subsequently visited ED in the following three months initially had lower blood eosinophil counts than those that did not make subsequent visits.

摘要

慢性阻塞性肺疾病急性加重(AECOPD)患者的住院治疗与相当高的死亡率和发病率相关,并且对医疗成本有很大影响。我们旨在确定区分需要住院治疗的AECOPD患者与不需要住院治疗的患者的潜在重要特征。:我们对先前进行的一项观察性研究进行了事后分析,该研究评估了因AECOPD住院或直接从急诊科(ED)出院的患者的出院记录。:总共纳入了N = 593例AECOPD患者(女性占37.4%):N = 225例(37.9%)住院,而368例(62.1%)从ED出院。患者的平均年龄为71(±9.14)岁。此外,64.7%的患者患有动脉高血压,住院患者中有60.4%、出院患者中有42.1%患有心血管疾病(不包括高血压)(P < 0.001)。此外,24%的住院患者患有糖尿病(而出院患者中这一比例为16.8%,P = 0.042)。出院患者的嗜酸性粒细胞计数中位数高于住院患者(P < 0.001)。在从ED出院的368例患者中,23.6%因AECOPD就诊于ED,50.6%在随后三个月内住院。在随后三个月内至少发生一次AECOPD的患者,其初始嗜酸性粒细胞计数显著低于未发生AECOPD的患者(P = 0.015)。:住院的AECOPD患者先前存在心血管疾病、糖尿病的患病率较高,血液嗜酸性粒细胞计数较低。在随后三个月内再次就诊于ED的患者,其初始血液嗜酸性粒细胞计数低于未再次就诊的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb8/12028299/640ecf3863c4/jcm-14-02855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb8/12028299/640ecf3863c4/jcm-14-02855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb8/12028299/640ecf3863c4/jcm-14-02855-g001.jpg

相似文献

1
Hospitalization Predictors in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Post Hoc Study of a Multicentric Retrospective Analysis.慢性阻塞性肺疾病急性加重期的住院预测因素:一项多中心回顾性分析的事后研究
J Clin Med. 2025 Apr 21;14(8):2855. doi: 10.3390/jcm14082855.
2
Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Are There Significant Differences Between Hospitalized and Emergency Department Patients?慢性阻塞性肺疾病急性加重:住院患者和急诊科患者之间有显著差异吗?
Int J Chron Obstruct Pulmon Dis. 2024 Jan 16;19:133-138. doi: 10.2147/COPD.S447477. eCollection 2024.
3
Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Subsequent Risk of Emergency Department Visits and Hospitalizations for Atrial Fibrillation.慢性阻塞性肺疾病急性加重与随后心房颤动急诊就诊和住院风险。
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006322. doi: 10.1161/CIRCEP.118.006322.
4
Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.慢性阻塞性肺疾病急性加重的急诊科管理:预测再入院的因素
Int J Chron Obstruct Pulmon Dis. 2018 May 23;13:1647-1654. doi: 10.2147/COPD.S163250. eCollection 2018.
5
Acute exacerbation of chronic obstructive pulmonary disease in United States emergency departments, 2010-2018.2010-2018 年美国急诊科慢性阻塞性肺疾病急性加重。
BMC Pulm Med. 2023 Jun 20;23(1):217. doi: 10.1186/s12890-023-02518-0.
6
Blood Eosinophil Levels and Prognosis of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.血液嗜酸性粒细胞水平与慢性阻塞性肺疾病急性加重住院患者的预后。
Am J Med Sci. 2021 Jul;362(1):56-62. doi: 10.1016/j.amjms.2021.02.013. Epub 2021 Feb 19.
7
Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease.经常利用急诊部门治疗慢性阻塞性肺疾病的急性加重。
Respir Res. 2014 Apr 10;15(1):40. doi: 10.1186/1465-9921-15-40.
8
Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.慢性阻塞性肺疾病急性加重住院治疗及相关卫生资源利用:基于人群的丹麦队列研究。
J Med Econ. 2013 Jul;16(7):897-906. doi: 10.3111/13696998.2013.800525. Epub 2013 May 23.
9
Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.住院 COPD 加重期血嗜酸性粒细胞增多及其稳定性与全因死亡率降低相关。
Int J Chron Obstruct Pulmon Dis. 2020 May 19;15:1123-1134. doi: 10.2147/COPD.S245056. eCollection 2020.
10
Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.慢性阻塞性肺疾病急性加重期血液嗜酸性粒细胞的稳定性及其与临床结局的关系:一项前瞻性队列研究。
Respir Res. 2021 Nov 24;22(1):301. doi: 10.1186/s12931-021-01888-5.

引用本文的文献

1
Modelling of biological age in stable and acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病稳定期和急性加重期生物学年龄的建模
BMC Pulm Med. 2025 Aug 19;25(1):398. doi: 10.1186/s12890-025-03841-4.

本文引用的文献

1
Risk of severe cardiovascular events following COPD exacerbations: results from the EXACOS-CV study in Spain.慢性阻塞性肺疾病急性加重后发生严重心血管事件的风险:西班牙EXACOS-CV研究的结果
Rev Esp Cardiol (Engl Ed). 2025 Jan;78(2):138-150. doi: 10.1016/j.rec.2024.06.003. Epub 2024 Jun 25.
2
Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.慢性阻塞性肺疾病加重增加后续心血管事件风险:COPDGene 研究的纵向分析。
J Am Heart Assoc. 2024 Jun 4;13(11):e033882. doi: 10.1161/JAHA.123.033882. Epub 2024 May 31.
3
Antibiotic treatment for patients with exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
抗生素治疗慢性阻塞性肺疾病加重患者:系统评价和荟萃分析。
Respir Investig. 2024 Jul;62(4):663-668. doi: 10.1016/j.resinv.2024.05.007. Epub 2024 May 17.
4
Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.COPD 急性加重后死亡和心血管事件的风险:EXACOS-CV 美国研究。
Int J Chron Obstruct Pulmon Dis. 2024 Jan 18;19:225-241. doi: 10.2147/COPD.S438893. eCollection 2024.
5
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后长期心血管风险增加。
Heart. 2024 Apr 25;110(10):702-709. doi: 10.1136/heartjnl-2023-323487.
6
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.英国初级保健中血嗜酸性粒细胞指导下的口服泼尼松龙治疗 COPD 加重(STARR2):一项非劣效性、多中心、双盲、安慰剂对照、随机对照试验。
Lancet Respir Med. 2024 Jan;12(1):67-77. doi: 10.1016/S2213-2600(23)00298-9. Epub 2023 Nov 2.
7
Are We Missing the Opportunity to Disseminate GOLD Recommendations Through AECOPD Discharge Letters?我们是否错过了通过 AECOPD 出院小结传播 GOLD 推荐的机会?
Int J Chron Obstruct Pulmon Dis. 2023 May 26;18:985-993. doi: 10.2147/COPD.S408307. eCollection 2023.
8
Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients.慢性阻塞性肺疾病急性加重的罗马严重程度分类在住院患者真实队列中的应用。
ERJ Open Res. 2023 May 15;9(3). doi: 10.1183/23120541.00569-2022. eCollection 2023 May.
9
Investigating the role of obstructive pulmonary diseases and eosinophil count at admission on all-cause mortality in SARS-CoV-2 patients : A single center registry-based retrospective cohort study.探讨入院时阻塞性肺疾病和嗜酸性粒细胞计数对 SARS-CoV-2 患者全因死亡率的作用:一项基于单中心登记的回顾性队列研究。
Wien Klin Wochenschr. 2023 May;135(9-10):235-243. doi: 10.1007/s00508-023-02180-w. Epub 2023 Apr 24.
10
Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?伴有频繁急性加重表型的慢性阻塞性肺疾病:这些患者有何不同?
Tanaffos. 2022 Mar;21(3):307-316.